title: Use of intravenous neuraminidase inhibitors during the 2009 pandemic: results from population-based surveillance.
authors.affiliation: Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. afry@cdc.gov
authors.forename: Alicia M
authors.initials: AM
authors.lastname: Fry
authors.forename: Alejandro
authors.initials: A
authors.lastname: Pérez
authors.forename: Lyn
authors.initials: L
authors.lastname: Finelli
mesh_terms: D000146:Acids, Carbocyclic; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003517:Cyclopentanes / Q000008:administration & dosage*; D004363:Drug Utilization; D004791:Enzyme Inhibitors / Q000008:administration & dosage*; D006146:Guanidines / Q000008:administration & dosage*; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000188:drug therapy* / Q000453:epidemiology; D007262:Infusions, Intravenous; D007297:Inpatients; D008875:Middle Aged; D011159:Population Surveillance; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D014481:United States / Q000453:epidemiology; D053243:Zanamivir / Q000008:administration & dosage*
chemical_list: D000146:Acids, Carbocyclic; D003517:Cyclopentanes; D004791:Enzyme Inhibitors; D006146:Guanidines; D053243:Zanamivir; C414210:peramivir